nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Cefdinir—MPO—urinary bladder cancer	0.00367	0.502	CrCbGaD
Cefuroxime—Cefaclor—MPO—urinary bladder cancer	0.00364	0.498	CrCbGaD
Cefuroxime—SLC15A1—epithelium—urinary bladder cancer	0.00166	0.154	CbGeAlD
Cefuroxime—SLC15A1—renal system—urinary bladder cancer	0.00154	0.143	CbGeAlD
Cefuroxime—SLC15A2—prostate gland—urinary bladder cancer	0.00141	0.131	CbGeAlD
Cefuroxime—SLC15A2—seminal vesicle—urinary bladder cancer	0.00119	0.111	CbGeAlD
Cefuroxime—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00118	0.0012	CcSEcCtD
Cefuroxime—Pancytopenia—Methotrexate—urinary bladder cancer	0.00118	0.0012	CcSEcCtD
Cefuroxime—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00118	0.0012	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00117	0.0012	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00117	0.00119	CcSEcCtD
Cefuroxime—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.00117	0.00119	CcSEcCtD
Cefuroxime—Dysuria—Methotrexate—urinary bladder cancer	0.00116	0.00118	CcSEcCtD
Cefuroxime—Neutropenia—Methotrexate—urinary bladder cancer	0.00116	0.00118	CcSEcCtD
Cefuroxime—Pruritus—Thiotepa—urinary bladder cancer	0.00116	0.00118	CcSEcCtD
Cefuroxime—Pain—Fluorouracil—urinary bladder cancer	0.00116	0.00118	CcSEcCtD
Cefuroxime—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00116	0.00118	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.00116	0.00118	CcSEcCtD
Cefuroxime—Tachycardia—Etoposide—urinary bladder cancer	0.00115	0.00117	CcSEcCtD
Cefuroxime—Eosinophilia—Epirubicin—urinary bladder cancer	0.00115	0.00117	CcSEcCtD
Cefuroxime—Dyspnoea—Cisplatin—urinary bladder cancer	0.00115	0.00117	CcSEcCtD
Cefuroxime—Skin disorder—Etoposide—urinary bladder cancer	0.00115	0.00117	CcSEcCtD
Cefuroxime—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00114	0.00116	CcSEcCtD
Cefuroxime—Anorexia—Etoposide—urinary bladder cancer	0.00112	0.00115	CcSEcCtD
Cefuroxime—Diarrhoea—Thiotepa—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Cefuroxime—Decreased appetite—Cisplatin—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Cefuroxime—Bronchitis—Epirubicin—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Cefuroxime—SLC15A1—vagina—urinary bladder cancer	0.00111	0.104	CbGeAlD
Cefuroxime—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00111	0.00113	CcSEcCtD
Cefuroxime—Infestation NOS—Methotrexate—urinary bladder cancer	0.00111	0.00113	CcSEcCtD
Cefuroxime—Infestation—Methotrexate—urinary bladder cancer	0.00111	0.00113	CcSEcCtD
Cefuroxime—Drowsiness—Methotrexate—urinary bladder cancer	0.00111	0.00113	CcSEcCtD
Cefuroxime—Pancytopenia—Epirubicin—urinary bladder cancer	0.0011	0.00113	CcSEcCtD
Cefuroxime—Pain—Cisplatin—urinary bladder cancer	0.0011	0.00112	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.0011	0.00112	CcSEcCtD
Cefuroxime—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00109	0.00111	CcSEcCtD
Cefuroxime—Renal failure—Methotrexate—urinary bladder cancer	0.00109	0.00111	CcSEcCtD
Cefuroxime—Dysuria—Epirubicin—urinary bladder cancer	0.00109	0.00111	CcSEcCtD
Cefuroxime—Neutropenia—Epirubicin—urinary bladder cancer	0.00109	0.00111	CcSEcCtD
Cefuroxime—Dizziness—Thiotepa—urinary bladder cancer	0.00109	0.00111	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.00108	0.0011	CcSEcCtD
Cefuroxime—Stomatitis—Methotrexate—urinary bladder cancer	0.00108	0.0011	CcSEcCtD
Cefuroxime—Urticaria—Fluorouracil—urinary bladder cancer	0.00108	0.0011	CcSEcCtD
Cefuroxime—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00107	0.00109	CcSEcCtD
Cefuroxime—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00107	0.00109	CcSEcCtD
Cefuroxime—Sweating—Methotrexate—urinary bladder cancer	0.00106	0.00108	CcSEcCtD
Cefuroxime—Dyspnoea—Etoposide—urinary bladder cancer	0.00105	0.00107	CcSEcCtD
Cefuroxime—Somnolence—Etoposide—urinary bladder cancer	0.00105	0.00107	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.00105	0.00107	CcSEcCtD
Cefuroxime—Vomiting—Thiotepa—urinary bladder cancer	0.00104	0.00106	CcSEcCtD
Cefuroxime—Infestation—Epirubicin—urinary bladder cancer	0.00104	0.00106	CcSEcCtD
Cefuroxime—Drowsiness—Epirubicin—urinary bladder cancer	0.00104	0.00106	CcSEcCtD
Cefuroxime—Infestation NOS—Epirubicin—urinary bladder cancer	0.00104	0.00106	CcSEcCtD
Cefuroxime—Rash—Thiotepa—urinary bladder cancer	0.00104	0.00105	CcSEcCtD
Cefuroxime—Bronchitis—Doxorubicin—urinary bladder cancer	0.00104	0.00105	CcSEcCtD
Cefuroxime—Dermatitis—Thiotepa—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Cefuroxime—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Cefuroxime—Headache—Thiotepa—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Cefuroxime—Decreased appetite—Etoposide—urinary bladder cancer	0.00103	0.00104	CcSEcCtD
Cefuroxime—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00102	0.00104	CcSEcCtD
Cefuroxime—Renal failure—Epirubicin—urinary bladder cancer	0.00102	0.00104	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00102	0.00104	CcSEcCtD
Cefuroxime—Body temperature increased—Cisplatin—urinary bladder cancer	0.00102	0.00104	CcSEcCtD
Cefuroxime—Jaundice—Epirubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Cefuroxime—Stomatitis—Epirubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Cefuroxime—Pain—Etoposide—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Cefuroxime—Urinary tract infection—Epirubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Cefuroxime—Neutropenia—Doxorubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Cefuroxime—Dysuria—Doxorubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Cefuroxime—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.001	0.00102	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.001	0.00102	CcSEcCtD
Cefuroxime—Haemoglobin—Methotrexate—urinary bladder cancer	0.001	0.00102	CcSEcCtD
Cefuroxime—Haemorrhage—Methotrexate—urinary bladder cancer	0.000995	0.00101	CcSEcCtD
Cefuroxime—Hepatitis—Methotrexate—urinary bladder cancer	0.000995	0.00101	CcSEcCtD
Cefuroxime—Sweating—Epirubicin—urinary bladder cancer	0.000994	0.00101	CcSEcCtD
Cefuroxime—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000983	0.001	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000981	0.000999	CcSEcCtD
Cefuroxime—Pruritus—Gemcitabine—urinary bladder cancer	0.000978	0.000996	CcSEcCtD
Cefuroxime—Nausea—Thiotepa—urinary bladder cancer	0.000976	0.000994	CcSEcCtD
Cefuroxime—Urethral disorder—Methotrexate—urinary bladder cancer	0.000975	0.000993	CcSEcCtD
Cefuroxime—Sinusitis—Epirubicin—urinary bladder cancer	0.000973	0.000991	CcSEcCtD
Cefuroxime—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000968	0.000986	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000965	0.000983	CcSEcCtD
Cefuroxime—Pruritus—Fluorouracil—urinary bladder cancer	0.000961	0.000979	CcSEcCtD
Cefuroxime—SLC15A2—renal system—urinary bladder cancer	0.000961	0.0895	CbGeAlD
Cefuroxime—Infestation NOS—Doxorubicin—urinary bladder cancer	0.00096	0.000977	CcSEcCtD
Cefuroxime—Infestation—Doxorubicin—urinary bladder cancer	0.00096	0.000977	CcSEcCtD
Cefuroxime—Drowsiness—Doxorubicin—urinary bladder cancer	0.00096	0.000977	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000951	0.000969	CcSEcCtD
Cefuroxime—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000949	0.000967	CcSEcCtD
Cefuroxime—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000946	0.000963	CcSEcCtD
Cefuroxime—SLC15A2—urethra—urinary bladder cancer	0.000944	0.088	CbGeAlD
Cefuroxime—Renal failure—Doxorubicin—urinary bladder cancer	0.000943	0.000961	CcSEcCtD
Cefuroxime—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000941	0.000958	CcSEcCtD
Cefuroxime—Urticaria—Etoposide—urinary bladder cancer	0.000938	0.000955	CcSEcCtD
Cefuroxime—Haemoglobin—Epirubicin—urinary bladder cancer	0.000936	0.000953	CcSEcCtD
Cefuroxime—Stomatitis—Doxorubicin—urinary bladder cancer	0.000935	0.000953	CcSEcCtD
Cefuroxime—Jaundice—Doxorubicin—urinary bladder cancer	0.000935	0.000953	CcSEcCtD
Cefuroxime—Body temperature increased—Etoposide—urinary bladder cancer	0.000933	0.00095	CcSEcCtD
Cefuroxime—Abdominal pain—Etoposide—urinary bladder cancer	0.000933	0.00095	CcSEcCtD
Cefuroxime—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000933	0.00095	CcSEcCtD
Cefuroxime—Hepatitis—Epirubicin—urinary bladder cancer	0.000931	0.000948	CcSEcCtD
Cefuroxime—Haemorrhage—Epirubicin—urinary bladder cancer	0.000931	0.000948	CcSEcCtD
Cefuroxime—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00093	0.000947	CcSEcCtD
Cefuroxime—Sweating—Doxorubicin—urinary bladder cancer	0.00092	0.000937	CcSEcCtD
Cefuroxime—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00092	0.000936	CcSEcCtD
Cefuroxime—Urethral disorder—Epirubicin—urinary bladder cancer	0.000913	0.00093	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000908	0.000924	CcSEcCtD
Cefuroxime—Angiopathy—Methotrexate—urinary bladder cancer	0.000903	0.000919	CcSEcCtD
Cefuroxime—Sinusitis—Doxorubicin—urinary bladder cancer	0.0009	0.000917	CcSEcCtD
Cefuroxime—Immune system disorder—Methotrexate—urinary bladder cancer	0.000899	0.000915	CcSEcCtD
Cefuroxime—Dizziness—Fluorouracil—urinary bladder cancer	0.000899	0.000915	CcSEcCtD
Cefuroxime—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000896	0.000912	CcSEcCtD
Cefuroxime—Chills—Methotrexate—urinary bladder cancer	0.000893	0.000909	CcSEcCtD
Cefuroxime—Diarrhoea—Cisplatin—urinary bladder cancer	0.000881	0.000898	CcSEcCtD
Cefuroxime—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00088	0.000897	CcSEcCtD
Cefuroxime—Vomiting—Gemcitabine—urinary bladder cancer	0.000879	0.000895	CcSEcCtD
Cefuroxime—Rash—Gemcitabine—urinary bladder cancer	0.000871	0.000887	CcSEcCtD
Cefuroxime—Dermatitis—Gemcitabine—urinary bladder cancer	0.000871	0.000887	CcSEcCtD
Cefuroxime—Hypersensitivity—Etoposide—urinary bladder cancer	0.000869	0.000885	CcSEcCtD
Cefuroxime—Erythema—Methotrexate—urinary bladder cancer	0.000866	0.000882	CcSEcCtD
Cefuroxime—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000866	0.000882	CcSEcCtD
Cefuroxime—Headache—Gemcitabine—urinary bladder cancer	0.000866	0.000882	CcSEcCtD
Cefuroxime—Vomiting—Fluorouracil—urinary bladder cancer	0.000864	0.00088	CcSEcCtD
Cefuroxime—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000862	0.000877	CcSEcCtD
Cefuroxime—Hepatitis—Doxorubicin—urinary bladder cancer	0.000862	0.000877	CcSEcCtD
Cefuroxime—Rash—Fluorouracil—urinary bladder cancer	0.000857	0.000873	CcSEcCtD
Cefuroxime—Dermatitis—Fluorouracil—urinary bladder cancer	0.000856	0.000872	CcSEcCtD
Cefuroxime—Headache—Fluorouracil—urinary bladder cancer	0.000851	0.000867	CcSEcCtD
Cefuroxime—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000851	0.000866	CcSEcCtD
Cefuroxime—Angiopathy—Epirubicin—urinary bladder cancer	0.000845	0.00086	CcSEcCtD
Cefuroxime—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000845	0.00086	CcSEcCtD
Cefuroxime—Immune system disorder—Epirubicin—urinary bladder cancer	0.000841	0.000856	CcSEcCtD
Cefuroxime—Chills—Epirubicin—urinary bladder cancer	0.000835	0.000851	CcSEcCtD
Cefuroxime—Pruritus—Etoposide—urinary bladder cancer	0.000835	0.00085	CcSEcCtD
Cefuroxime—Nausea—Gemcitabine—urinary bladder cancer	0.000821	0.000836	CcSEcCtD
Cefuroxime—Vomiting—Cisplatin—urinary bladder cancer	0.000819	0.000834	CcSEcCtD
Cefuroxime—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000815	0.00083	CcSEcCtD
Cefuroxime—Rash—Cisplatin—urinary bladder cancer	0.000812	0.000827	CcSEcCtD
Cefuroxime—Dermatitis—Cisplatin—urinary bladder cancer	0.000811	0.000826	CcSEcCtD
Cefuroxime—Erythema—Epirubicin—urinary bladder cancer	0.000811	0.000825	CcSEcCtD
Cefuroxime—Diarrhoea—Etoposide—urinary bladder cancer	0.000807	0.000822	CcSEcCtD
Cefuroxime—Nausea—Fluorouracil—urinary bladder cancer	0.000807	0.000822	CcSEcCtD
Cefuroxime—Flatulence—Epirubicin—urinary bladder cancer	0.000799	0.000813	CcSEcCtD
Cefuroxime—Angiopathy—Doxorubicin—urinary bladder cancer	0.000782	0.000796	CcSEcCtD
Cefuroxime—Dizziness—Etoposide—urinary bladder cancer	0.00078	0.000795	CcSEcCtD
Cefuroxime—Muscle spasms—Epirubicin—urinary bladder cancer	0.000779	0.000794	CcSEcCtD
Cefuroxime—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000778	0.000792	CcSEcCtD
Cefuroxime—Leukopenia—Methotrexate—urinary bladder cancer	0.000775	0.00079	CcSEcCtD
Cefuroxime—Chills—Doxorubicin—urinary bladder cancer	0.000773	0.000787	CcSEcCtD
Cefuroxime—SLC15A2—female reproductive system—urinary bladder cancer	0.00077	0.0717	CbGeAlD
Cefuroxime—Nausea—Cisplatin—urinary bladder cancer	0.000765	0.000779	CcSEcCtD
Cefuroxime—Cough—Methotrexate—urinary bladder cancer	0.000756	0.00077	CcSEcCtD
Cefuroxime—Convulsion—Methotrexate—urinary bladder cancer	0.00075	0.000764	CcSEcCtD
Cefuroxime—Vomiting—Etoposide—urinary bladder cancer	0.00075	0.000764	CcSEcCtD
Cefuroxime—Erythema—Doxorubicin—urinary bladder cancer	0.00075	0.000764	CcSEcCtD
Cefuroxime—Agitation—Epirubicin—urinary bladder cancer	0.000745	0.000759	CcSEcCtD
Cefuroxime—Rash—Etoposide—urinary bladder cancer	0.000744	0.000758	CcSEcCtD
Cefuroxime—Dermatitis—Etoposide—urinary bladder cancer	0.000743	0.000757	CcSEcCtD
Cefuroxime—Headache—Etoposide—urinary bladder cancer	0.000739	0.000753	CcSEcCtD
Cefuroxime—Flatulence—Doxorubicin—urinary bladder cancer	0.000739	0.000753	CcSEcCtD
Cefuroxime—Arthralgia—Methotrexate—urinary bladder cancer	0.000737	0.000751	CcSEcCtD
Cefuroxime—Chest pain—Methotrexate—urinary bladder cancer	0.000737	0.000751	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000732	0.000746	CcSEcCtD
Cefuroxime—Leukopenia—Epirubicin—urinary bladder cancer	0.000726	0.000739	CcSEcCtD
Cefuroxime—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000721	0.000734	CcSEcCtD
Cefuroxime—Palpitations—Epirubicin—urinary bladder cancer	0.000716	0.000729	CcSEcCtD
Cefuroxime—Cough—Epirubicin—urinary bladder cancer	0.000707	0.00072	CcSEcCtD
Cefuroxime—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000707	0.00072	CcSEcCtD
Cefuroxime—Convulsion—Epirubicin—urinary bladder cancer	0.000702	0.000715	CcSEcCtD
Cefuroxime—Nausea—Etoposide—urinary bladder cancer	0.000701	0.000714	CcSEcCtD
Cefuroxime—SLC15A2—vagina—urinary bladder cancer	0.000696	0.0649	CbGeAlD
Cefuroxime—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000692	0.000705	CcSEcCtD
Cefuroxime—Arthralgia—Epirubicin—urinary bladder cancer	0.00069	0.000703	CcSEcCtD
Cefuroxime—Chest pain—Epirubicin—urinary bladder cancer	0.00069	0.000703	CcSEcCtD
Cefuroxime—Agitation—Doxorubicin—urinary bladder cancer	0.000689	0.000702	CcSEcCtD
Cefuroxime—Skin disorder—Methotrexate—urinary bladder cancer	0.000687	0.000699	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000685	0.000698	CcSEcCtD
Cefuroxime—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000683	0.000696	CcSEcCtD
Cefuroxime—Anorexia—Methotrexate—urinary bladder cancer	0.000674	0.000686	CcSEcCtD
Cefuroxime—Leukopenia—Doxorubicin—urinary bladder cancer	0.000671	0.000684	CcSEcCtD
Cefuroxime—Palpitations—Doxorubicin—urinary bladder cancer	0.000663	0.000675	CcSEcCtD
Cefuroxime—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000662	0.000674	CcSEcCtD
Cefuroxime—Cough—Doxorubicin—urinary bladder cancer	0.000654	0.000666	CcSEcCtD
Cefuroxime—Convulsion—Doxorubicin—urinary bladder cancer	0.00065	0.000662	CcSEcCtD
Cefuroxime—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000648	0.00066	CcSEcCtD
Cefuroxime—Tachycardia—Epirubicin—urinary bladder cancer	0.000646	0.000658	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000644	0.000656	CcSEcCtD
Cefuroxime—Skin disorder—Epirubicin—urinary bladder cancer	0.000643	0.000654	CcSEcCtD
Cefuroxime—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00064	0.000651	CcSEcCtD
Cefuroxime—Chest pain—Doxorubicin—urinary bladder cancer	0.000639	0.00065	CcSEcCtD
Cefuroxime—Arthralgia—Doxorubicin—urinary bladder cancer	0.000639	0.00065	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000634	0.000646	CcSEcCtD
Cefuroxime—Anorexia—Epirubicin—urinary bladder cancer	0.000631	0.000642	CcSEcCtD
Cefuroxime—Dyspnoea—Methotrexate—urinary bladder cancer	0.00063	0.000642	CcSEcCtD
Cefuroxime—Somnolence—Methotrexate—urinary bladder cancer	0.000628	0.00064	CcSEcCtD
Cefuroxime—Dyspepsia—Methotrexate—urinary bladder cancer	0.000622	0.000634	CcSEcCtD
Cefuroxime—Decreased appetite—Methotrexate—urinary bladder cancer	0.000614	0.000626	CcSEcCtD
Cefuroxime—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000612	0.000623	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00061	0.000621	CcSEcCtD
Cefuroxime—Pain—Methotrexate—urinary bladder cancer	0.000604	0.000616	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000603	0.000614	CcSEcCtD
Cefuroxime—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000599	0.00061	CcSEcCtD
Cefuroxime—Tachycardia—Doxorubicin—urinary bladder cancer	0.000597	0.000608	CcSEcCtD
Cefuroxime—Skin disorder—Doxorubicin—urinary bladder cancer	0.000595	0.000605	CcSEcCtD
Cefuroxime—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000592	0.000603	CcSEcCtD
Cefuroxime—Dyspnoea—Epirubicin—urinary bladder cancer	0.00059	0.000601	CcSEcCtD
Cefuroxime—Somnolence—Epirubicin—urinary bladder cancer	0.000588	0.000599	CcSEcCtD
Cefuroxime—Anorexia—Doxorubicin—urinary bladder cancer	0.000583	0.000594	CcSEcCtD
Cefuroxime—Dyspepsia—Epirubicin—urinary bladder cancer	0.000582	0.000593	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000578	0.000589	CcSEcCtD
Cefuroxime—Decreased appetite—Epirubicin—urinary bladder cancer	0.000575	0.000586	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000571	0.000582	CcSEcCtD
Cefuroxime—Pain—Epirubicin—urinary bladder cancer	0.000566	0.000576	CcSEcCtD
Cefuroxime—Urticaria—Methotrexate—urinary bladder cancer	0.000562	0.000572	CcSEcCtD
Cefuroxime—Body temperature increased—Methotrexate—urinary bladder cancer	0.000559	0.000569	CcSEcCtD
Cefuroxime—Abdominal pain—Methotrexate—urinary bladder cancer	0.000559	0.000569	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000558	0.000568	CcSEcCtD
Cefuroxime—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000546	0.000556	CcSEcCtD
Cefuroxime—Somnolence—Doxorubicin—urinary bladder cancer	0.000544	0.000554	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000541	0.000551	CcSEcCtD
Cefuroxime—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000539	0.000549	CcSEcCtD
Cefuroxime—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000532	0.000542	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000528	0.000538	CcSEcCtD
Cefuroxime—Urticaria—Epirubicin—urinary bladder cancer	0.000526	0.000535	CcSEcCtD
Cefuroxime—Pain—Doxorubicin—urinary bladder cancer	0.000523	0.000533	CcSEcCtD
Cefuroxime—Abdominal pain—Epirubicin—urinary bladder cancer	0.000523	0.000533	CcSEcCtD
Cefuroxime—Body temperature increased—Epirubicin—urinary bladder cancer	0.000523	0.000533	CcSEcCtD
Cefuroxime—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000521	0.00053	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000501	0.00051	CcSEcCtD
Cefuroxime—Pruritus—Methotrexate—urinary bladder cancer	0.0005	0.000509	CcSEcCtD
Cefuroxime—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000487	0.000496	CcSEcCtD
Cefuroxime—Urticaria—Doxorubicin—urinary bladder cancer	0.000486	0.000495	CcSEcCtD
Cefuroxime—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000484	0.000493	CcSEcCtD
Cefuroxime—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000484	0.000493	CcSEcCtD
Cefuroxime—Diarrhoea—Methotrexate—urinary bladder cancer	0.000484	0.000493	CcSEcCtD
Cefuroxime—Pruritus—Epirubicin—urinary bladder cancer	0.000468	0.000477	CcSEcCtD
Cefuroxime—Dizziness—Methotrexate—urinary bladder cancer	0.000467	0.000476	CcSEcCtD
Cefuroxime—Diarrhoea—Epirubicin—urinary bladder cancer	0.000453	0.000461	CcSEcCtD
Cefuroxime—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000451	0.000459	CcSEcCtD
Cefuroxime—SLC15A2—lymph node—urinary bladder cancer	0.00045	0.042	CbGeAlD
Cefuroxime—Vomiting—Methotrexate—urinary bladder cancer	0.000449	0.000458	CcSEcCtD
Cefuroxime—Rash—Methotrexate—urinary bladder cancer	0.000446	0.000454	CcSEcCtD
Cefuroxime—Dermatitis—Methotrexate—urinary bladder cancer	0.000445	0.000453	CcSEcCtD
Cefuroxime—Headache—Methotrexate—urinary bladder cancer	0.000443	0.000451	CcSEcCtD
Cefuroxime—Dizziness—Epirubicin—urinary bladder cancer	0.000437	0.000445	CcSEcCtD
Cefuroxime—Pruritus—Doxorubicin—urinary bladder cancer	0.000433	0.000441	CcSEcCtD
Cefuroxime—Vomiting—Epirubicin—urinary bladder cancer	0.000421	0.000428	CcSEcCtD
Cefuroxime—Nausea—Methotrexate—urinary bladder cancer	0.00042	0.000428	CcSEcCtD
Cefuroxime—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000419	0.000426	CcSEcCtD
Cefuroxime—Rash—Epirubicin—urinary bladder cancer	0.000417	0.000425	CcSEcCtD
Cefuroxime—Dermatitis—Epirubicin—urinary bladder cancer	0.000417	0.000424	CcSEcCtD
Cefuroxime—Headache—Epirubicin—urinary bladder cancer	0.000414	0.000422	CcSEcCtD
Cefuroxime—Dizziness—Doxorubicin—urinary bladder cancer	0.000405	0.000412	CcSEcCtD
Cefuroxime—Nausea—Epirubicin—urinary bladder cancer	0.000393	0.0004	CcSEcCtD
Cefuroxime—Vomiting—Doxorubicin—urinary bladder cancer	0.000389	0.000396	CcSEcCtD
Cefuroxime—Rash—Doxorubicin—urinary bladder cancer	0.000386	0.000393	CcSEcCtD
Cefuroxime—Dermatitis—Doxorubicin—urinary bladder cancer	0.000386	0.000393	CcSEcCtD
Cefuroxime—Headache—Doxorubicin—urinary bladder cancer	0.000383	0.000391	CcSEcCtD
Cefuroxime—Nausea—Doxorubicin—urinary bladder cancer	0.000364	0.00037	CcSEcCtD
